Skip to main content
HeartCited

Resveratrol 用于 高血压

B 证据 至少一项随机试验支持这一结论,结果基本一致。

Meta-analysis: systolic -11.9 mmHg in hypertensives at >=150 mg/day. Improved flow-mediated dilation in multiple RCTs. Bioavailability limitations noted.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

Meta-analysis: systolic -11.9 mmHg in hypertensives at >=150 mg/day. Improved flow-mediated dilation in multiple RCTs. Bioavailability limitations noted.

Key Study Findings

Review
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk.
Dose: None vs: None Outcome: None 效果: None None

研究人群: review of nutrition and lifestyle interventions for dyslipidemia and cardiometabolic risk

Review
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.
Dose: None vs: None Outcome: None 效果: None None

研究人群: review of age-related cardiac dysfunction and heart failure mechanisms

Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily vs: Placebo Outcome: Preeclampsia risk reduction 效果: ~50% risk reduction None

研究人群: Pregnant women with low calcium intake

Systematic Review
The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.
Dose: None vs: Placebo or no treatment Outcome: Cardiometabolic changes in menopausal women 效果: None None

研究人群: Menopausal women

Controlled Clinical Trial
Resveratrol inhibits cerebral aneurysms in mice via downregulating the NF-κB pathway.
Dose: None vs: Model group (no RES) and sham control Outcome: Cerebral aneurysm formation 效果: None P<0.05

研究人群: Mice with induced hypertension CA model

Review
The Role of Resveratrol Administration in Human Obesity.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Obese adults

Key Statistics

10

研究数量

600

受试者

Positive

B

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
150-500 mg/day
cardiovascularsupport:
250-500 mg/day trans-resveratrol

上限: Not formally established; GI discomfort common above 1,000 mg/day

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive --
None -- Neutral --
500 mg daily -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
75 mg 14 weeks Positive 129
None -- Mixed --

最佳服用时间: With meals; bioavailability enhanced by piperine co-supplementation

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (nausea, diarrhea, cramping) at high doses
  • Headache
  • May have estrogenic activity at high doses

已知相互作用

  • Anticoagulants (may inhibit platelet aggregation)
  • CYP450 substrates (may inhibit CYP1A2, CYP3A4, CYP2D6)
  • Blood pressure medications (additive hypotensive effect)
  • Estrogen-sensitive conditions (weak estrogenic activity)

可耐受最高摄入量: Not formally established; GI discomfort common above 1,000 mg/day

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Resveratrol help with 高血压?
Based on 10 studies with 600 participants, there is moderate evidence from clinical studies that Resveratrol may support 高血压 management. Our evidence grade is B (Good Evidence).
How much Resveratrol should I take for 高血压?
Studies have used various dosages. A commonly studied range is 150-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, cramping) at high doses, Headache, May have estrogenic activity at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and 高血压?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

References

  1. [1] Zhuyubing Fang et al.. ESC Heart Fail. 2025. Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues. doi:10.1002/ehf2.14947 PubMed
  2. [2] Hygerta Berisha et al.. Nutrients. 2025. Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk. doi:10.3390/nu17050776 PubMed
  3. [3] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
  4. [4] Ali Amini et al.. Cardiovasc Hematol Disord Drug Targets. 2025. The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review. doi:10.2174/011871529X398468250910225946 PubMed
  5. [5] Tao Jin et al.. Acta Biochim Pol. 2022. Resveratrol inhibits cerebral aneurysms in mice via downregulating the NF-κB pathway. doi:10.18388/abp.2020_5982 PubMed
  6. [6] Laura M Mongioì et al.. Int J Mol Sci. 2021. The Role of Resveratrol Administration in Human Obesity. doi:10.3390/ijms22094362 PubMed
  7. [7] Jay Jay Thaung Zaw et al.. Nutrients. 2020. Sustained Cerebrovascular and Cognitive Benefits of Resveratrol in Postmenopausal Women. doi:10.3390/nu12030828 PubMed
  8. [8] Raúl Francisco Pastor et al.. Nutrients. 2020. Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome. doi:10.3390/nu12103149 PubMed
  9. [9] Ligia J Dominguez et al.. Acta Biomed. 2018. Nutritional prevention of cognitive decline and dementia. doi:10.23750/abm.v89i2.7401 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。